Abstract | Objective: Research Design and Methods: Retrospective, nested case-control study using data from national VA Corporate Data Warehouse. All adult patients with type 2 diabetes and CKD newly dispensed any antihyperglycaemic medication during FY 2003-13 were included. The outcome was LA hospitalization or serum lactate >5 mEq/L. Exposure to metformin was evaluated in the three months prior to event. Estimates were adjusted for 31 covariates, including demographics, comorbidities and medications. Results: Overall, 320 882 patients were included, contributing a total of 1 331 784 person-years of follow-up. LA occurred in 2 665 patients, generating an overall incidence rate of 2.00 (95% CI 1.93-2.08) per 1000 person-years. Metformin exposure in the prior 3 months was associated with an elevated adjusted hazard of LA (HR 1.97, 95% CI 1.69-2.29). No association was evident in patients with CKD stage 1 or 2 (HR 1.05, 95% CI 0.71-1.57), but associations were present and progressively greater in patients with CKD stage 3a through 5: HR 3.09, 95% CI 2.19-4.35 in CKD 3a, HR 3.34, 95% CI 1.95-5.72 in CKD 3b, HR 7.87, 95% CI 3.51-17.61 in CKD stage 4&5. Conclusion:
Metformin was not associated with an elevated risk of LA in persons with stage 1-2 CKD, but was associated with a progressively higher risk at more advanced stages of CKD.
|
Authors | Carlos A Alvarez, Ethan A Halm, Mary Jo V Pugh, Darren K McGuire, Sean Hennessy, Richard T Miller, Ildiko Lingvay, Scott M Vouri, Andrew R Zullo, Hui Yang, Matt Chansard, Eric M Mortensen |
Journal | Endocrinology, diabetes & metabolism
(Endocrinol Diabetes Metab)
Vol. 4
Issue 1
Pg. e00170
(01 2021)
ISSN: 2398-9238 [Electronic] England |
PMID | 33532612
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.)
|
Copyright | © 2020 The Authors. Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd. |
Chemical References |
|
Topics |
- Acidosis, Lactic
(etiology)
- Aged
- Case-Control Studies
- Diabetes Mellitus, Type 2
(complications, drug therapy)
- Female
- Follow-Up Studies
- Humans
- Incidence
- Male
- Metformin
(adverse effects)
- Middle Aged
- Negative Results
- Propensity Score
- Renal Insufficiency, Chronic
(complications)
- Retrospective Studies
- Risk
- Time Factors
|